Industry News (Joint Venture)

Technology and Expertise To Develop Cell and Gene Therapy Network

Published in Gene Therapy Weekly, November 6th, 1995

Aastrom Biosciences, Inc., Ann Arbor, Michigan, and Rhone-Poulenc Rorer Inc. (RPR), Collegeville, Pennsylvania, announced a collaboration to develop the automated Aastrom Cell Production System (CPS) for cell and gene therapies involving lymphoid blood cells, a strategic focus within RPR Gencell, a division of RPR.

The agreement provides Aastrom with a partner to accelerate the development of the automated Aastrom CPS for lymphoid cell and gene therapies. This market includes patients with AIDS, cancer and other immune disorders.

The agreement gives RPR rights to use and sell Aastrom technology and products on a worldwide basis with potential to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-11-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry